Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways Murine L929 fibrosarcoma cells were transfected with the human Fas (APO-1/CD95) receptor, and the role of various caspases in Fas-mediated cell death was assessed. Proteolytic activation of procaspase-3 and -7 was shown by Western analysis. Acetyl-Tyr-Val-Ala-Asp-chloromethylketone and benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone, tetrapeptide inhibitors of caspase-1– and caspase-3–like proteases, respectively, failed to block Fas-induced apoptosis. Unexpectedly, the broad-spectrum caspase inhibitors benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone and benzyloxycarbonyl-Asp(OMe)-fluoromethylketone rendered the cells even more sensitive to Fas-mediated cell death, as measured after 18 h incubation. However, when the process was followed microscopically, it became clear that anti-Fas–induced apoptosis of Fas-transfected L929 cells was blocked during the first 3 h, and subsequently the cells died by necrosis. As in tumor necrosis factor (TNF)-induced necrosis, Fas treatment led to accumulation of reactive oxygen radicals, and Fas-mediated necrosis was inhibited by the oxygen radical scavenger butylated hydroxyanisole. However, in contrast to TNF, anti-Fas did not activate the nuclear factor κB under these necrotic conditions. These results demonstrate the existence of two different pathways originating from the Fas receptor, one rapidly leading to apoptosis, and, if this apoptotic pathway is blocked by caspase inhibitors, a second directing the cells to necrosis and involving oxygen radical production. Fas antigen apoptosis necrosis caspases oxygen radicals Footnotes Research was supported by the Interuniversitaire Attractiepolen, grant 9005097N of the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen, and European Community Biomed Program grant BMH4-CT96-0300. G. Denecker is a research assistant, and P. Vandenabeele a postdoctoral researcher with the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen. Abbreviations used in this paper: Ac-DEVD-amc acetyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-aminomethylcoumarin Ac-YVAD-amc acetyl-Tyr-Val-Ala-Asp-aminomethylcoumarin Ac-YVAD-cmk acetyl-Tyr-Val-Ala-Asp-chloromethylketone BHA butylated hydroxyanisole DD death domain DR death receptor DHR123 dihydrorhodamine, 123 FADD Fas-associated DD protein L929hFas Fas-transfected L929 (cells) MORT mediator of receptor-induced toxicity NF-κB nuclear factor κB PI propidium iodide TRADD TNFR-associated DD protein TRAIL TNF- related apoptosis–inducing ligand zAAD-cmk benzyloxycarbonyl-Ala-Ala-Asp-chloromethylketone zDEVD-fmk benzyloxycarbonyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-fluoromethylketone zD-fmk benzyloxycarbonyl-Asp(OMe)-fluoromethylketone zVAD-afc benzyloxycarbonyl-Val-Ala-Asp(OMe)-aminotrifluoromethylcoumarin zVAD-fmk benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone Submitted: 4 May 1998 Revision received 10 June 1998 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Experimental Medicine Rockefeller University Press

Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

Loading next page...
 
/lp/rockefeller-university-press/dual-signaling-of-the-fas-receptor-initiation-of-both-apoptotic-and-y7un8Fs4OT
Publisher
Rockefeller University Press
Copyright
© 1998 Rockefeller University Press
ISSN
0022-1007
eISSN
1540-9538
D.O.I.
10.1084/jem.188.5.919
Publisher site
See Article on Publisher Site

Abstract

Murine L929 fibrosarcoma cells were transfected with the human Fas (APO-1/CD95) receptor, and the role of various caspases in Fas-mediated cell death was assessed. Proteolytic activation of procaspase-3 and -7 was shown by Western analysis. Acetyl-Tyr-Val-Ala-Asp-chloromethylketone and benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone, tetrapeptide inhibitors of caspase-1– and caspase-3–like proteases, respectively, failed to block Fas-induced apoptosis. Unexpectedly, the broad-spectrum caspase inhibitors benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone and benzyloxycarbonyl-Asp(OMe)-fluoromethylketone rendered the cells even more sensitive to Fas-mediated cell death, as measured after 18 h incubation. However, when the process was followed microscopically, it became clear that anti-Fas–induced apoptosis of Fas-transfected L929 cells was blocked during the first 3 h, and subsequently the cells died by necrosis. As in tumor necrosis factor (TNF)-induced necrosis, Fas treatment led to accumulation of reactive oxygen radicals, and Fas-mediated necrosis was inhibited by the oxygen radical scavenger butylated hydroxyanisole. However, in contrast to TNF, anti-Fas did not activate the nuclear factor κB under these necrotic conditions. These results demonstrate the existence of two different pathways originating from the Fas receptor, one rapidly leading to apoptosis, and, if this apoptotic pathway is blocked by caspase inhibitors, a second directing the cells to necrosis and involving oxygen radical production. Fas antigen apoptosis necrosis caspases oxygen radicals Footnotes Research was supported by the Interuniversitaire Attractiepolen, grant 9005097N of the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen, and European Community Biomed Program grant BMH4-CT96-0300. G. Denecker is a research assistant, and P. Vandenabeele a postdoctoral researcher with the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen. Abbreviations used in this paper: Ac-DEVD-amc acetyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-aminomethylcoumarin Ac-YVAD-amc acetyl-Tyr-Val-Ala-Asp-aminomethylcoumarin Ac-YVAD-cmk acetyl-Tyr-Val-Ala-Asp-chloromethylketone BHA butylated hydroxyanisole DD death domain DR death receptor DHR123 dihydrorhodamine, 123 FADD Fas-associated DD protein L929hFas Fas-transfected L929 (cells) MORT mediator of receptor-induced toxicity NF-κB nuclear factor κB PI propidium iodide TRADD TNFR-associated DD protein TRAIL TNF- related apoptosis–inducing ligand zAAD-cmk benzyloxycarbonyl-Ala-Ala-Asp-chloromethylketone zDEVD-fmk benzyloxycarbonyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-fluoromethylketone zD-fmk benzyloxycarbonyl-Asp(OMe)-fluoromethylketone zVAD-afc benzyloxycarbonyl-Val-Ala-Asp(OMe)-aminotrifluoromethylcoumarin zVAD-fmk benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone Submitted: 4 May 1998 Revision received 10 June 1998

Journal

The Journal of Experimental MedicineRockefeller University Press

Published: Sep 7, 1998

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off